{"transactions":[{"id":690910,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-11T21:56:22.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":500,"price":26.33,"value":13165.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.3150 to $26.3600. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":60609,"source":{"system":"sec-edgar","filing":"0001193125-26-345169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526345169/ownership.xml","form_type":"4"}},{"id":690909,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-11T21:56:22.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":25787,"price":25.8742,"value":667217.9954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.3100 to $26.3050. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":61109,"source":{"system":"sec-edgar","filing":"0001193125-26-345169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526345169/ownership.xml","form_type":"4"}},{"id":694316,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-06T23:04:25.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":3915,"price":25.1696,"value":98538.984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.0000 to $25.3800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":86896,"source":{"system":"sec-edgar","filing":"0001193125-26-338665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526338665/ownership.xml","form_type":"4"}},{"id":694315,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-06T23:04:25.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":3080,"price":24.057,"value":74095.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9030 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":90811,"source":{"system":"sec-edgar","filing":"0001193125-26-338665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526338665/ownership.xml","form_type":"4"}},{"id":698983,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-03T23:30:34.000Z","date":"2026-08-03","kind":"sale","planned":false,"acquired":false,"shares":5391,"price":23.8012,"value":128312.2692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":93891,"source":{"system":"sec-edgar","filing":"0001193125-26-331062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526331062/ownership.xml","form_type":"4"}},{"id":698982,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-03T23:30:34.000Z","date":"2026-07-31","kind":"sale","planned":false,"acquired":false,"shares":8817,"price":22.6091,"value":199344.4347,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1600 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":99282,"source":{"system":"sec-edgar","filing":"0001193125-26-331062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526331062/ownership.xml","form_type":"4"}},{"id":698981,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-03T23:30:34.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":3980,"price":22.7539,"value":90560.522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3300 to $23.0300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":108099,"source":{"system":"sec-edgar","filing":"0001193125-26-331062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526331062/ownership.xml","form_type":"4"}},{"id":707002,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-07-17T21:50:40.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":44118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares earned with respect to an award of performance-based RSUs (\"PSUs\") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026."}],"balance_after":112079,"source":{"system":"sec-edgar","filing":"0001193125-26-308045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526308045/ownership.xml","form_type":"4"}},{"id":749789,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-06-04T22:37:57.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. (\"Common Share\"). Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9."}],"balance_after":67961,"source":{"system":"sec-edgar","filing":"0001193125-26-257911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526257911/ownership.xml","form_type":"4"}},{"id":1084123,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-07-21T21:14:36.000Z","date":"2025-07-17","kind":"grant","planned":false,"acquired":true,"shares":22059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 7,353 on July 17, 2026, 7,353 on July 17, 2027 and 7,354 on July 17, 2028."}],"balance_after":36897,"source":{"system":"sec-edgar","filing":"0000950170-25-097321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025097321/ownership.xml","form_type":"4"}},{"id":3194634,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-26T16:36:18.000Z","date":"2020-03-24","kind":"tax_withholding","acquired":false,"shares":3625,"price":0.94,"value":3407.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on March 24, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on March 11, 2020."}],"balance_after":111716,"source":{"system":"sec-edgar","filing":"0001013606-20-000048","document":"wf-form4_158525496049212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000048/wf-form4_158525496049212.xml","form_type":"4"}},{"id":3194633,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-26T16:36:18.000Z","date":"2020-03-24","kind":"grant","acquired":true,"shares":47010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2019. 8,865 shares subject to this restricted stock unit award vested based on the achievement of specified Company performance criteria pursuant to the terms of this award."}],"balance_after":115341,"source":{"system":"sec-edgar","filing":"0001013606-20-000048","document":"wf-form4_158525496049212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000048/wf-form4_158525496049212.xml","form_type":"4"}},{"id":3327793,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:15:32.000Z","date":"2019-12-30","kind":"tax_withholding","acquired":false,"shares":3393,"price":1.68,"value":5700.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on December 30, 2019 to satisfy statutory minimum tax withholding obligations related to shares vested on December 30, 2019."}],"balance_after":115341,"source":{"system":"sec-edgar","filing":"0001013606-20-000004","document":"wf-form4_157799971520536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000004/wf-form4_157799971520536.xml","form_type":"4"}},{"id":3327792,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:15:32.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":47010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2019. 50% of the 20,147 shares subject to this restricted stock unit award vested pursuant to the terms of this award."}],"balance_after":118734,"source":{"system":"sec-edgar","filing":"0001013606-20-000004","document":"wf-form4_157799971520536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000004/wf-form4_157799971520536.xml","form_type":"4"}},{"id":3339616,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-17T14:17:26.000Z","date":"2019-12-13","kind":"tax_withholding","acquired":false,"shares":2986,"price":2.545,"value":7599.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on December 13, 2019 to satisfy statutory minimum tax withholding obligations related to shares vested on December 04, 2019."}],"balance_after":118733,"source":{"system":"sec-edgar","filing":"0001013606-19-000194","document":"wf-form4_157661022809711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000194/wf-form4_157661022809711.xml","form_type":"4"}},{"id":3339615,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-17T14:17:26.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":47010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2019. 33% percent of the 28,863 shares subject to this restricted stock award vested pursuant to the terms of this award."}],"balance_after":121719,"source":{"system":"sec-edgar","filing":"0001013606-19-000194","document":"wf-form4_157661022809711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000194/wf-form4_157661022809711.xml","form_type":"4"}},{"id":3403563,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:56.000Z","date":"2019-09-27","kind":"grant","acquired":true,"shares":10959,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The options vest in three equal annual installments over a three-year period commencing on September 10, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 13,702 shares of common stock granted to the reporting person on October 15, 2015, (ii) an option for 11,594 shares of common stock granted to the reporting person on February 4, 2016, and (iii) an option for 10,999 shares of common stock granted to the reporting person on May 31, 2017. In exchange, the reporting person received a new stock option, for 10,959 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":10959,"derivative":{"exercise_price":4.71,"exercise_date":"2020-09-10","expiration_date":"2026-09-10","underlying":"Common Stock","underlying_shares":10959},"source":{"system":"sec-edgar","filing":"0001013606-19-000170","document":"wf-form4_156996183385541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000170/wf-form4_156996183385541.xml","form_type":"4"}},{"id":3403562,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:56.000Z","date":"2019-09-27","kind":"disposition_to_issuer","acquired":false,"shares":10999,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options vested ratably over forty-eight months."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 13,702 shares of common stock granted to the reporting person on October 15, 2015, (ii) an option for 11,594 shares of common stock granted to the reporting person on February 4, 2016, and (iii) an option for 10,999 shares of common stock granted to the reporting person on May 31, 2017. In exchange, the reporting person received a new stock option, for 10,959 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":48.2,"exercise_date":"2017-06-30","expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":10999},"source":{"system":"sec-edgar","filing":"0001013606-19-000170","document":"wf-form4_156996183385541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000170/wf-form4_156996183385541.xml","form_type":"4"}},{"id":3403561,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:56.000Z","date":"2019-09-27","kind":"disposition_to_issuer","acquired":false,"shares":11594,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options vested ratably over forty-eight months."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 13,702 shares of common stock granted to the reporting person on October 15, 2015, (ii) an option for 11,594 shares of common stock granted to the reporting person on February 4, 2016, and (iii) an option for 10,999 shares of common stock granted to the reporting person on May 31, 2017. In exchange, the reporting person received a new stock option, for 10,959 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":75.3,"exercise_date":"2016-03-04","expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":11594},"source":{"system":"sec-edgar","filing":"0001013606-19-000170","document":"wf-form4_156996183385541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000170/wf-form4_156996183385541.xml","form_type":"4"}},{"id":3403560,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:56.000Z","date":"2019-09-27","kind":"disposition_to_issuer","acquired":false,"shares":13702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 13,702 shares of common stock granted to the reporting person on October 15, 2015, (ii) an option for 11,594 shares of common stock granted to the reporting person on February 4, 2016, and (iii) an option for 10,999 shares of common stock granted to the reporting person on May 31, 2017. In exchange, the reporting person received a new stock option, for 10,959 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":135.6,"exercise_date":"2016-10-15","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":13702},"source":{"system":"sec-edgar","filing":"0001013606-19-000170","document":"wf-form4_156996183385541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000170/wf-form4_156996183385541.xml","form_type":"4"}},{"id":3445946,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-08-06T17:16:29.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":64800,"price":6.67,"value":432216.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options vest ratably over thirty-six months."}],"balance_after":64800,"derivative":{"exercise_price":6.67,"exercise_date":"2019-09-05","expiration_date":"2029-08-05","underlying":"Common Stock","underlying_shares":64800},"source":{"system":"sec-edgar","filing":"0001013606-19-000134","document":"wf-form4_156512616822805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000134/wf-form4_156512616822805.xml","form_type":"4"}},{"id":3445945,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-06T17:16:29.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":32400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance restricted stock unit award based on predetermined goals."}],"balance_after":121720,"source":{"system":"sec-edgar","filing":"0001013606-19-000134","document":"wf-form4_156512616822805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000134/wf-form4_156512616822805.xml","form_type":"4"}},{"id":3550969,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-23T19:15:59.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":20935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022."}],"balance_after":20935,"derivative":{"exercise_price":6.36,"expiration_date":"2029-03-03","underlying":"Common Stock","underlying_shares":20935},"source":{"system":"sec-edgar","filing":"0001209191-19-025633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025633/doc4.xml","form_type":"4"}},{"id":3550968,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-23T19:15:59.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total reported in Column 5 includes 6,000 RSUs previously reported in Table II on 2/21/18."}],"balance_after":14083,"source":{"system":"sec-edgar","filing":"0001209191-19-025633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025633/doc4.xml","form_type":"4"}},{"id":3552286,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-19T21:35:39.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":20935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022."}],"balance_after":20935,"derivative":{"exercise_price":6.36,"expiration_date":"2029-03-03","underlying":"Common Stock","underlying_shares":20935},"source":{"system":"sec-edgar","filing":"0001209191-19-025412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025412/doc4.xml","form_type":"4"}},{"id":3552285,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-19T21:35:39.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total reported in Column 5 includes 6,000 RSUs previously reported in Table II on 2/21/18."}],"balance_after":14083,"source":{"system":"sec-edgar","filing":"0001209191-19-025412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025412/doc4.xml","form_type":"4"}},{"id":3566122,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-03T16:16:29.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the time-based restricted stock unit award shall vest on October 3, 2019 and shall settle in shares of common stock."}],"balance_after":89320,"source":{"system":"sec-edgar","filing":"0001013606-19-000076","document":"wf-form4_155432257105252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000076/wf-form4_155432257105252.xml","form_type":"4"}},{"id":3566121,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-03T16:16:29.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":15128,"price":6.61,"value":99996.08,"ownership":{"direct":true},"balance_after":76820,"source":{"system":"sec-edgar","filing":"0001013606-19-000076","document":"wf-form4_155432257105252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000076/wf-form4_155432257105252.xml","form_type":"4"}},{"id":3714702,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2019-01-02T21:01:30.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":225621,"price":0.7445,"value":167974.8345,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the option award shall vest on December 30, 2019."}],"balance_after":225621,"derivative":{"exercise_price":0.7445,"exercise_date":"2019-12-30","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":225621},"source":{"system":"sec-edgar","filing":"0001013606-19-000021","document":"wf-form4_154648087116506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000021/wf-form4_154648087116506.xml","form_type":"4"}},{"id":3714701,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-02T21:01:30.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":470115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"(i) 201,478 time-based restricted stock units (RSUs) vest in two equal annual installments on December 30, 2019 and December 30, 2020, and (ii) 268,637 RSUs vest as to 100% of the underlying shares on December 30, 2021, provided that the vesting of the RSUs shall be subject to acceleration based on the achievement of specified Company and/or individual performance criteria to be approved by the Company's compensation committee. All RSUs granted shall settle in shares of common stock on each of the dates indicated."}],"balance_after":616927,"source":{"system":"sec-edgar","filing":"0001013606-19-000021","document":"wf-form4_154648087116506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000021/wf-form4_154648087116506.xml","form_type":"4"}},{"id":3838787,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2018-08-20T16:19:43.000Z","date":"2018-08-16","kind":"purchase","acquired":true,"shares":30000,"price":2.43,"value":72900.0,"ownership":{"direct":true},"balance_after":146812,"source":{"system":"sec-edgar","filing":"0001013606-18-000126","document":"wf-form4_153479636718221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000126/wf-form4_153479636718221.xml","form_type":"4"}},{"id":3995092,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Quality"}}],"security":"Common Shares","published_at":"2018-03-15T16:26:14.000Z","date":"2018-03-13","kind":"disposition_to_issuer","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares subject to this Form 4 were granted as part of a performance restricted stock unit granted May 31, 2017. All shares granted have been forfeited due to the single performance milestone being deemed not achievable by the Company."}],"balance_after":116812,"source":{"system":"sec-edgar","filing":"0001013606-18-000029","document":"wf-form4_152114556039329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000029/wf-form4_152114556039329.xml","form_type":"4"}},{"id":4039547,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-22T14:45:54.000Z","date":"2018-01-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of restricted stock units (\"RSUs\") awarded to the Reporting Person on January 30, 2018. The RSUs vest on the one year anniversary of the date of grant, so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of restricted stock units (\"RSUs\") awarded to the Reporting Person on January 30, 2018. The RSUs vest on the one year anniversary of the date of grant, so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-012262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919118012262/doc4.xml","form_type":"4"}},{"id":4039546,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-22T14:45:54.000Z","date":"2018-01-30","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on January 30, 2021."}],"balance_after":24000,"derivative":{"exercise_price":9.8,"expiration_date":"2021-01-29","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-18-012262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919118012262/doc4.xml","form_type":"4"}},{"id":4069079,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2018-02-09T17:55:51.000Z","date":"2018-02-07","kind":"tax_withholding","acquired":false,"shares":4632,"price":4.05,"value":18759.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold on February 7, 2018 to satisfy statutory minimum tax withholding obligations related to shares vested on February 4, 2018."}],"balance_after":144812,"source":{"system":"sec-edgar","filing":"0001013606-18-000012","document":"wf-form4_151821693730639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000012/wf-form4_151821693730639.xml","form_type":"4"}},{"id":4069078,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2018-02-09T17:55:51.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":33201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on February 17, 2016. 33% of the shares subject to this restricted stock award vested pursuant the terms of this award."}],"balance_after":149444,"source":{"system":"sec-edgar","filing":"0001013606-18-000012","document":"wf-form4_151821693730639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000012/wf-form4_151821693730639.xml","form_type":"4"}},{"id":4169401,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-11-08T16:12:52.000Z","date":"2017-11-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Fifty percent of the restricted stock units shall vest eighteen months after date of grant, and the remaining balance will vest 36 months after the date of grant, in each case subject to continued service on the applicable vesting date."}],"balance_after":149444,"source":{"system":"sec-edgar","filing":"0001013606-17-000168","document":"wf-form4_151017555336951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000168/wf-form4_151017555336951.xml","form_type":"4"}},{"id":4296602,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase","published_at":"2017-06-02T16:34:45.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":110000,"price":4.82,"value":530200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options vest ratably over forty-eight months."}],"balance_after":110000,"derivative":{"exercise_price":4.82,"exercise_date":"2017-06-30","expiration_date":"2027-05-31","underlying":"Option to Purchase","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001013606-17-000097","document":"wf-form4_149643566933301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000097/wf-form4_149643566933301.xml","form_type":"4"}},{"id":4296601,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-06-02T16:34:45.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance restricted stock unit award based on a sales milestone."}],"balance_after":121186,"source":{"system":"sec-edgar","filing":"0001013606-17-000097","document":"wf-form4_149643566933301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000097/wf-form4_149643566933301.xml","form_type":"4"}},{"id":4356297,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-04-07T13:15:02.000Z","date":"2017-04-06","kind":"tax_withholding","acquired":false,"shares":5184,"price":6.75,"value":34992.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold on April 6, 2017 to satisfy statutory minimum tax withholding obligations related to shares vested on April 4, 2017."}],"balance_after":93186,"source":{"system":"sec-edgar","filing":"0001013606-17-000039","document":"wf-form4_149158528745009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000039/wf-form4_149158528745009.xml","form_type":"4"}},{"id":4356296,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-04-07T13:15:02.000Z","date":"2017-04-06","kind":"grant","acquired":true,"shares":55310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on October 16, 2015. 25% percent of the shares subject to this restricted stock award vested pursuant the terms of this award."}],"balance_after":98370,"source":{"system":"sec-edgar","filing":"0001013606-17-000039","document":"wf-form4_149158528745009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000039/wf-form4_149158528745009.xml","form_type":"4"}},{"id":4418733,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-02-28T13:55:44.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":5222,"price":6.41,"value":33473.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold on February 27, 2017 to satisfy statutory minimum tax withholding obligations related to shares vested on February 22, 2017."}],"balance_after":98370,"source":{"system":"sec-edgar","filing":"0001013606-17-000028","document":"wf-form4_148830813030304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000028/wf-form4_148830813030304.xml","form_type":"4"}},{"id":4418732,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-02-28T13:55:44.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":55310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on October 16, 2015. 25% percent of the shares subject to this restricted stock award vested pursuant the terms of this award."}],"balance_after":103592,"source":{"system":"sec-edgar","filing":"0001013606-17-000028","document":"wf-form4_148830813030304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000028/wf-form4_148830813030304.xml","form_type":"4"}},{"id":4460027,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-02-09T15:13:14.000Z","date":"2017-02-07","kind":"tax_withholding","acquired":false,"shares":4919,"price":6.94,"value":34137.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold on February 7, 2017 to satisfy statutory minimum tax withholding obligations related to shares vested on February 4, 2017."}],"balance_after":103592,"source":{"system":"sec-edgar","filing":"0001013606-17-000016","document":"wf-form4_148667118099033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000016/wf-form4_148667118099033.xml","form_type":"4"}},{"id":4460026,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2017-02-09T15:13:14.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":33201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on February 17, 2016. 33% percent of the shares subject to this restricted stock award vested pursuant the terms of this award."}],"balance_after":108511,"source":{"system":"sec-edgar","filing":"0001013606-17-000016","document":"wf-form4_148667118099033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000016/wf-form4_148667118099033.xml","form_type":"4"}},{"id":4520901,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":24645,"kind":"person","name":"Mahboob Vaseem","position":1,"cik":"0001655157","reported_name":"Mahboob Vaseem","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2016-12-15T16:52:55.000Z","date":"2016-12-13","kind":"purchase","acquired":true,"shares":20000,"price":6.25,"value":125000.0,"ownership":{"direct":true},"balance_after":108511,"source":{"system":"sec-edgar","filing":"0001013606-16-000333","document":"wf-form4_148183876343555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360616000333/wf-form4_148183876343555.xml","form_type":"4"}}]}